PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Bisect Therapeutics, Inc., 45 Dan Road, Canton, MA, USA.\', \'Orthogon Therapeutics LLC, 960 Turnpike St, Canton, MA, USA.\', \'National Emerging Infectious Diseases Laboratories (NEIDL), 620 Albany Street, Boston, MA, 02118, USA.\', \'Department of Biochemistry, Boston University School of Medicine, Boston, MA, USA.\', \'Department of Microbiology, Boston University School of Medicine, Boston, MA, USA.\', \'Biofizik, Inc., 9865 Mesa Rim Road, San Diego, CA, USA.\', \'Pledge Therapeutics B.V., Gaston Geenslaan 1, Leuven, 3000, Belgium.\', \'National Emerging Infectious Diseases Laboratories (NEIDL), 620 Albany Street, Boston, MA, 02118, USA. msaeed1@bu.edu.\', \'Department of Biochemistry, Boston University School of Medicine, Boston, MA, USA. msaeed1@bu.edu.\', \'Bisect Therapeutics, Inc., 45 Dan Road, Canton, MA, USA. amunawar@bisect-tx.com.\', \'Orthogon Therapeutics LLC, 960 Turnpike St, Canton, MA, USA. amunawar@bisect-tx.com.\', \'Pledge Therapeutics B.V., Gaston Geenslaan 1, Leuven, 3000, Belgium. amunawar@bisect-tx.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41598-021-84782-w
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 33686143
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33686143>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33686143>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all